Non-alcoholic fatty liver disease (NAFLD) is a common disorder that now affects up to one third of the adult population. It is increasingly common in children.The major significance of NAFLD is that:
(i) it is linked to a high risk for type 2 diabetes, metabolic syndrome and resultant cardiovascular disease and some cancers, and
(ii) its form, non-alcoholic steatohepatitis (NASH), can lead to cirrhosis and its complications.
Fatty liver attributable to metabolic factors will be discussed here in the context of NAFLD/NASH.
However, it may also co-exist with and worsen liver disease caused by alcohol, hepatitis C, haemochromatosis and some drugs, such as methotrexate. Ways to counter the present epidemic of obesity and fatty liver are an important part of management for all common liver problems.

First Edition 2007.
To save document to your computer, right-click on the link, and select Save Target As. To view the document, click the link. This file requires Adobe Reader software to view.